AliveCor earns $3M in Series A financing

Mobile electrocardiogram developer AliveCor just snagged a huge cash infusion without even having a product on the market. Wireless and telecom company QualComm, along with the Oklahoma Life Science Fund and a few other investors, handed AliveCor $3 million to help bring its wireless cardiac monitor to market. The device still needs to complete clinical studies, ongoing at the Oklahoma University Health Sciences Center and obtain U.S. Food and Drug Administration approvals before it's ready for commercial launch, company officials say. Announcement

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.